Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes.
Telmisartan, an angiotensin II-receptor blocker (ARB), is a partial agonist of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma). We investigated whether telmisartan improved the pathophysiology of myocardial infarction in diabetes partial..... Read More